Back

LRP3 (low-density lipoprotein receptor-related protein 3), potential metabolic-inflammatory dual regulatory targets of atherosclerosis

29 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Chao Zhai

Peking University First Hospital, Beijing (China)

7 More presentations in this session

Presentation thumbnail
Autoantibodies against apolipoprotein A-1 and cadmium: possible links to cardiovascular and liver diseases across multiple models
Doctor S. Pagano (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Electronegative H5 HDL: an apo(a)-containing HDL that damages neuronal DNA by potentially disrupting the BBB
Assistant Professor W. Hsu (Yunlin, TW)
Abstract Slides Video
Presentation thumbnail
The role and mechanism of METTL14/CCN3 axis in lipoprotein (a) [Lp(a)] induced human aortic smooth muscle cell calcification
Doctor Z. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells
Doctor P. Mason (Boston, US)
Abstract Slides Video
Presentation thumbnail
Nanoformulated omega-3 rich linseed oil reversed IL-6+TNF-a-induced M1 polarized THP-1 cells and monocytes of healthy donors and the activated monocytes of patients with coronary artery disease
Miss S. Hmadeh (Strasbourg, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
From genes to trials in China: Lp(a) and ANGPTL3/4/8 as emerging atherosclerotic cardiovascular disease targets beyond LDL-C and inflammation?
29 August 2025
thumbnail
Congress Presentation
Relation of high sensitivity c-reactive protein and low-density lipoprotein-cholesterol level to coronary artery plaque morphology and plaque rupture in patients with acute coronary syndromes
1 September 2025
thumbnail
Congress Presentation
Inhibition of ceramide de novo synthesis mitigates atherosclerosis
1 September 2024
thumbnail
Congress Presentation
Plasma proteomic profiling reveals distinct lipoprotein roles in atherosclerosis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources